Analysis of gyrA mutations in quinolone-resistant and -susceptible Campylobacter jejuni isolates from retail poultry and human clinical isolates by non-radioactive single-strand conformation polymorphism analysis and DNA sequencing

被引:23
作者
Beckmann, L
Müller, M
Luber, P
Schrader, C
Bartelt, E
Klein, G
机构
[1] Tierarztl Hsch Hanover, Zenrtum Lebensmittelwissensch, D-30173 Hannover, Germany
[2] Bundesinst Risikobewertung, Berlin, Germany
关键词
Campylobacter jejuni; fluoroquinolone resistance; foods of animal origin (chicken; turkey); human clinical isolates; single-strand conformation polymorphism analysis;
D O I
10.1111/j.1365-2672.2004.02242.x
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
Aims: The alms of this study were to characterize the molecular variations in the quinolone resistance-determining region (QRDR) of gyrA among quinolone-resistant and -susceptible Campylobacter jejuni isolates originating from foods of animal origin and human infections and to evaluate the suitability of the single-strand conformation polymorphism (SSCP) method as a screening method for molecular characterization of fluoroquinolone resistance. Methods and Results: Alterations in QRDR of gyrA from 182 C. Jejuni isolates were determined by nonradioisotopic SSCP analysis and direct sequencing. A total of 13 types of nucleic acid sequence combinations within the QRDR of the gyrA gene resulted in 11 different SSCP patterns. All nalidixic acid resistant strains possessed nucleotide substitution at either codon Thr-86 or Asp-90. Silent mutations were detected additionally. Thr-86 to Ile mutation was detected in all 139 ciprofloxacin resistant strains, which showed cross-resistance to nalidixic acid. Conclusions: The SSCP method is suitable for a molecular screening of quinolone resistant C. Jejuni isolates and in combination with DNA sequencing suitable to detect genetic variations of the QRDR of gyrA. Significance and Impact of Study: This study provides data of the genetic variations of the QRDR of gyrA from C. jejuni isolates of foods and human beings.
引用
收藏
页码:1040 / 1047
页数:8
相关论文
共 44 条
[1]   Trends in bacterial resistance to fluoroquinolones [J].
Acar, JF ;
Goldstein, FW .
CLINICAL INFECTIOUS DISEASES, 1997, 24 :S67-S73
[2]   Single or double mutational alterations of GyrA associated with fluoroquinolone resistance in Campylobacter jejuni and Campylobacter coli [J].
Bachoual, R ;
Ouabdesselam, S ;
Mory, F ;
Lascols, C ;
Soussy, CJ ;
Tankovic, J .
MICROBIAL DRUG RESISTANCE, 2001, 7 (03) :257-261
[3]   COMPARISON OF SELECTIVE MEDIA FOR ISOLATION OF CAMPYLOBACTER-JEJUNI-COLI [J].
BOLTON, FJ ;
COATES, D ;
HINCHLIFFE, PM ;
ROBERTSON, L .
JOURNAL OF CLINICAL PATHOLOGY, 1983, 36 (01) :78-83
[4]  
Carattoli A, 2002, FEMS MICROBIOL LETT, V214, P87, DOI 10.1111/j.1574-6968.2002.tb11329.x
[5]  
Charvalos E, 1996, J CLIN LAB ANAL, V10, P129, DOI 10.1002/(SICI)1098-2825(1996)10:3<129::AID-JCLA3>3.0.CO
[6]  
2-6
[7]   Genetic basis of quinolone resistance and epidemiology of resistant and susceptible isolates of porcine Campylobacter coli strains [J].
Cooper, R ;
Segal, H ;
Lastovica, AJ ;
Elisha, BG .
JOURNAL OF APPLIED MICROBIOLOGY, 2002, 93 (02) :241-249
[8]  
Drlica K, 1999, ASM NEWS, V65, P410
[9]   Quinolone and macrolide resistance in Campylobacter jejuni and C-coli:: Resistance mechanisms and trends in human isolates [J].
Engberg, J ;
Aarestrup, FM ;
Taylor, DE ;
Gerner-Smidt, P ;
Nachamkin, I .
EMERGING INFECTIOUS DISEASES, 2001, 7 (01) :24-34
[10]  
Friedman C.R., 2000, CAMPYLOBACTER, V2nd, P121